These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 2156857

  • 1. DNA methylation and collagen IV gene expression in F9 teratocarcinoma cells.
    Burbelo PD, Horikoshi S, Yamada Y.
    J Biol Chem; 1990 Mar 25; 265(9):4839-43. PubMed ID: 2156857
    [Abstract] [Full Text] [Related]

  • 2. Increases in mRNA concentrations of the alpha and beta subunits of prolyl 4-hydroxylase accompany increased gene expression of type IV collagen during differentiation of mouse F9 cells.
    Helaakoski T, Pajunen L, Kivirikko KI, Pihlajaniemi T.
    J Biol Chem; 1990 Jul 15; 265(20):11413-6. PubMed ID: 1694844
    [Abstract] [Full Text] [Related]

  • 3. Isolation of cDNA clones specific for collagen IV and laminin from mouse teratocarcinoma cells.
    Wang SY, Gudas LJ.
    Proc Natl Acad Sci U S A; 1983 Oct 15; 80(19):5880-4. PubMed ID: 6310600
    [Abstract] [Full Text] [Related]

  • 4. Defective post-translational modification of collagen IV in a mutant F9 teratocarcinoma cell line is associated with delayed differentiation and growth arrest in response to retinoic acid.
    Wang SY, Roguska MA, Gudas LJ.
    J Biol Chem; 1989 Sep 15; 264(26):15556-64. PubMed ID: 2549067
    [Abstract] [Full Text] [Related]

  • 5. Protein synthesis inhibitors prevent the induction of laminin B1, collagen IV (alpha 1), and other differentiation-specific mRNAs by retinoic acid in F9 teratocarcinoma cells.
    Wang SY, Gudas LJ.
    J Cell Physiol; 1988 Aug 15; 136(2):305-11. PubMed ID: 2842348
    [Abstract] [Full Text] [Related]

  • 6. Activation of collagen IV gene expression in F9 teratocarcinoma cells by 3-deazaadenosine analogs. Indirect inhibitors of methylation.
    Chiang PK, Burbelo PD, Brugh SA, Gordon RK, Fukuda K, Yamada Y.
    J Biol Chem; 1992 Mar 05; 267(7):4988-91. PubMed ID: 1537874
    [Abstract] [Full Text] [Related]

  • 7. A retinoic acid/cAMP-responsive enhancer containing a cAMP responsive element is required for the activation of the mouse thrombomodulin-encoding gene in differentiating F9 cells.
    Niforas P, Chu MD, Bird P.
    Gene; 1996 Oct 17; 176(1-2):139-47. PubMed ID: 8918245
    [Abstract] [Full Text] [Related]

  • 8. Molecular cloning of gene sequences transcriptionally regulated by retinoic acid and dibutyryl cyclic AMP in cultured mouse teratocarcinoma cells.
    Wang SY, LaRosa GJ, Gudas LJ.
    Dev Biol; 1985 Jan 17; 107(1):75-86. PubMed ID: 2981185
    [Abstract] [Full Text] [Related]

  • 9. Induction of alpha-fetoprotein synthesis in differentiating F9 teratocarcinoma cells is accompanied by a genome-wide loss of DNA methylation.
    Young PR, Tilghman SM.
    Mol Cell Biol; 1984 May 17; 4(5):898-907. PubMed ID: 6203029
    [Abstract] [Full Text] [Related]

  • 10. Reversible effects of dibutyryl cAMP on laminin and type IV collagen secretion from retinoic acid treated F9 cells.
    Morita A, Kitagawa Y, Sugimoto E.
    J Cell Physiol; 1985 Nov 17; 125(2):263-72. PubMed ID: 2997239
    [Abstract] [Full Text] [Related]

  • 11. The beta 1,4-galactosyltransferase gene is post-transcriptionally regulated during differentiation of mouse F9 teratocarcinoma cells.
    Kudo T, Narimatsu H.
    Glycobiology; 1995 Jun 17; 5(4):397-403. PubMed ID: 7579794
    [Abstract] [Full Text] [Related]

  • 12. Two-stage hormonal control of type IV collagen mRNA levels during differentiation of F9 teratocarcinoma cells.
    Marotti KR, Brown GD, Strickland S.
    Dev Biol; 1985 Mar 17; 108(1):26-31. PubMed ID: 2579001
    [Abstract] [Full Text] [Related]

  • 13. Selection and characterization of F9 teratocarcinoma stem cell mutants with altered responses to retinoic acid.
    Wang SY, Gudas LJ.
    J Biol Chem; 1984 May 10; 259(9):5899-906. PubMed ID: 6325455
    [Abstract] [Full Text] [Related]

  • 14. Sec61alpha synthesis is enhanced during translocation of nascent chains of collagen type IV in F9 teratocarcinoma cells after retinoic acid treatment.
    Ferreira LR, Velano CE, Braga EC, Paula CC, Marteli H, Sauk JJ.
    Braz J Med Biol Res; 2003 Jan 10; 36(1):29-37. PubMed ID: 12532224
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of the cellular retinoic acid binding protein-I (CRABP-I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells.
    Boylan JF, Gudas LJ.
    J Cell Biol; 1991 Mar 10; 112(5):965-79. PubMed ID: 1847931
    [Abstract] [Full Text] [Related]

  • 16. Posttranscriptional regulation of the expression of CAD gene during differentiation of F9 teratocarcinoma cells by induction with retinoic acid and dibutyryl cyclic AMP.
    Rao GN, Church RL, Davidson JN.
    FEBS Lett; 1988 May 09; 232(1):238-42. PubMed ID: 2896607
    [Abstract] [Full Text] [Related]

  • 17. Decrease in the c-myb gene transcript during differentiation of mouse teratocarcinoma stem cells.
    Fukuda M, Ikuma S, Setoyama C, Shimada K.
    Biochem Int; 1987 Jul 09; 15(1):73-9. PubMed ID: 2840075
    [Abstract] [Full Text] [Related]

  • 18. Ultraviolet irradiation, although it activates the transcription factor AP-1 in F9 teratocarcinoma stem cells, does not induce the full complement of differentiation-associated genes.
    Auer HP, König H, Litfin M, Stein B, Rahmsdorf HJ.
    Exp Cell Res; 1994 Sep 09; 214(1):131-8. PubMed ID: 7521841
    [Abstract] [Full Text] [Related]

  • 19. Differentiation-responsive elements in the 5' region of the mouse tissue plasminogen activator gene confer two-stage regulation by retinoic acid and cyclic AMP in teratocarcinoma cells.
    Rickles RJ, Darrow AL, Strickland S.
    Mol Cell Biol; 1989 Apr 09; 9(4):1691-704. PubMed ID: 2542775
    [Abstract] [Full Text] [Related]

  • 20. The regulation of the expression of genes encoding basement membrane proteins during the retinoic acid-associated differentiation of murine teratocarcinoma cells.
    Gudas LJ, Grippo JF, Kim KW, Larosa GJ, Stoner CM.
    Ann N Y Acad Sci; 1990 Apr 09; 580():245-51. PubMed ID: 2337299
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.